Press Releases Cosmo Pharmaceuticals N.V.

Equities

COPN

NL0011832936

Delayed Swiss Exchange Other stock markets 09:14:00 2024-04-29 am EDT			5-day change	1st Jan Change
71.9 ^CHF	+0.42%		-2.04%	+41.26%

Apr. 26	Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024	CI
Apr. 25	Cosmo Pharmaceuticals Names New CEO, Chairman	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmo Announces Leadership Changes	Apr. 25	NE
Cosmo and Medtronic unveil the future of AI in GI, Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care	Apr. 15	AQ
Cosmo and Medtronic Unveil the Future of AI in GI: Genius Summit 2024 Reveals Innovations and Collaborations That Advance Endoscopic Care	Apr. 12	NE
Cosmo and Medtronic unveil the future of AI in GI: Genius Summit 2024 reveals innovations and collaborations that advance endoscopic care	Apr. 12	PU
Cosmo Pharmaceuticals N : ESG Report 2023	Mar. 20	PU
Cosmo Reports Excellent Preliminary Unaudited Full Year 2023 Core Financial Results - Record Guidance for 2024 - Doubles Dividend to 2.00 per Share	Mar. 20	NE
Cosmo Pharmaceuticals N : reports excellent preliminary unaudited Full Year 2023 core financial results – Record guidance for 2024 – Doubles dividend to € 2.00 per share	Mar. 20	PU
Cosmo Pharmaceuticals Announces Approval of Winlevi(R) in Australia	Mar. 19	NE
Cosmo Pharmaceuticals N : announces approval of Winlevi® in Australia	Mar. 19	PU
Invitation to Cosmo's Investor Day and Full-Year 2023 Webcast, Zurich, 20 March 2024	Jan. 26	AQ
Invitation to Cosmo's Investor Day and Full-Year 2023 Webcast - Zurich, 20 March 2024	Jan. 25	NE
Cosmo Pharmaceuticals and Medtronic Forge Ahead in AI-Driven Care	Dec. 11	NE
Cosmo confirms full redemption in cash of €175m Convertible Bonds	Dec. 06	EQ
Cosmo announces submission of Winlevi® to the European Medicines Agency (EMA)	23-10-10	EQ
Cosmo and Hikma Sign License Agreement for Winlevi® in 17 Middle Eastern and North African Countries	23-10-02	EQ
COSMO AND GLENMARK ANNOUNCE THE SIGNING OF DISTRIBUTION AND LICENSE AGREEMENTS FOR WINLEVI IN EUROPE AND SOUTH AFRICA	23-09-28	AQ
Cosmo and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africa	23-09-27	EQ
Cosmo Pharmaceuticals N : and Glenmark announce the signing of Distribution and License Agreements for Winlevi® in Europe and South Africaert title here.	23-09-27	PU
Cosmo and Adalvo sign License and Supply Agreement for Rifamycin SV MMX® 200mg in Europe, APAC, MENA and LATAM regions	23-09-04	EQ
Termination of Agreement for Rifamycin SV MMX® with Dr. Falk Pharma	23-09-04	EQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Cosmo Pharmaceuticals N.V.

Equities

COPN

NL0011832936

Press Releases

Filters